Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04846088 · ClinicalTrials.gov registry record · NA
A Study to Characterize Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouches in Adult Cigarette Smokers
A NA study, sponsored by British American Tobacco (Investments) Limited.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT04846088 is a NA study that has completed, run by British American Tobacco (Investments) Limited. The registered enrollment target is 42 participants.
The verdict
NCT04846088, a NA study, has completed, sponsored by British American Tobacco (Investments) Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study is designed to evaluate plasma nicotine pharmacokinetic (PK) parameters following the use of nicotine pouches in cigarette smokers who have experience with use of smokeless tobacco (SST) \[e.g., snus, moist snuff\].
Interventions
- OTHER Product A
- OTHER Product B
- OTHER Product C
- OTHER Product D
- OTHER Product E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-04-05 |
| Est. Completion | 2021-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04846088
The ClinicalTrials.gov registry entry for NCT04846088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is British American Tobacco (Investments) Limited, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Product A is the first listed.
NCT04846088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04846088 about?
NCT04846088 is a clinical study titled "A Study to Characterize Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouches in Adult Cigarette Smokers". This study is designed to evaluate plasma nicotine pharmacokinetic (PK) parameters following the use of nicotine pouches in cigarette smokers who have experience with use of smokeless tobacco (SST) \[e.g., snus, moist snuff\].
What is the current status of trial NCT04846088?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-04-05. Estimated completion is 2021-06-02.
What interventions are being tested in trial NCT04846088?
The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product E (OTHER).
Who is sponsoring clinical trial NCT04846088?
This trial is sponsored by British American Tobacco (Investments) Limited, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.